Nabil Adra
Papers
1
Total Citations
2
H-Index
1
About
Nabil Adra is a leading oncologist and researcher whose work focuses on genitourinary malignancies, particularly testicular cancer and germ cell tumors. His major contributions include advancing the understanding of surgical and oncologic outcomes in patients with early metastatic seminoma, as demonstrated in his multi-institutional retrospective study published in the *Journal of Urology* (2023). This work, which has garnered early citations, sheds light on the role of post-chemotherapy retroperitoneal lymph node dissection in this patient population, helping to refine treatment paradigms and improve patient selection for surgery. Beyond this study, Dr. Adra is recognized for his expertise in developing novel therapeutic strategies for testicular cancer, including the integration of immunotherapy and targeted agents. His research has been instrumental in shaping clinical guidelines and improving survival outcomes for patients with advanced germ cell tumors. With a career dedicated to bridging the gap between clinical practice and translational research, Dr. Adra’s work continues to influence urologic oncology, making him a respected voice in the field and a valuable resource for trainees and colleagues alike.
Research Focus
Key Achievements
Top Papers
- 1